Gary Cohn, 72, formerly of Philadelphia, an Inquirer alum who went on to win a Pulitzer Prize at the Baltimore Sun during a decades-long career devoted to investigative reporting, died Monday, Dec. 23 ...

After a tough year marked by policy uncertainty and lagging fundamentals, healthcare stocks are set to change course in 2025, Citi says. The firm points to better valuations for the sector ...

The Boxing Day sales are in full swing at Debenhams, and there are some unmissable money-saving deals to be had. The online department store has launched its biggest-ever December 26 discount ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

The rights to a catalog of prints from Lilly Pulitzer's early years — including many created by the artist the famed fashion designer credited with the "Lilly Look" — are now officially part ...

Eli Lilly announced FDA approval of Zepbound as the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea. In addition, adults on Zepbound lost an average of 45 ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment ...

Some people spend thousands of dollars to buy their dream wedding dress, while others might wear a family heirloom or repurpose a special outfit. But teacher Emma Wilson had her wedding dress made ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...